Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer closes Ferrosan Consumer Health deal

This article was originally published in Scrip

Executive Summary

Pfizer says it has closed its purchase of the consumer healthcare firm, Ferrosan. The US firm announced its intention to buy the Danish company earlier this year (scripintelligence.com, 7 February 2011). Ferrosan's business includes dietary supplements and lifestyle products and should broaden Pfizer's own portfolio. "Ferrosan Consumer Health's innovative products and geographic footprint are a strong fit for our business," said Paul Sturman, president of Pfizer Consumer Healthcare. The financial details of the deal have not been disclosed.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015416

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel